PRCM
PARN

Pine River Capital Management’s Parnell Pharmaceuticals Holdings Ltd PARN Stock Holding History

Pine River Capital Management’s Portfolio PARN Stock Details PARN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-73,653
Closed -$424K – 1110
2014
Q3 		$424K Hold
73,653
– – 0.01% 792
2014
Q2 		$508K Buy
+73,653
New +$566K 0.01% 596

Other funds holding PARN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Pine River Capital Management's PARN Position: Q4 2014 in Review

Pine River Capital Management sold out of Parnell Pharmaceuticals Holdings Ltd (PARN) in Q4 2014, closing a stake of 73,653 shares — an estimated $424K sold.

Pine River Capital Management first reported a position in PARN in Q2 2014 and held it in 2 quarters. The position peaked at $508K in Q2 2014. 18 funds tracked by Wall St. Rank hold PARN as of Q4 2014.

  • Pine River Capital Management reported no remaining Parnell Pharmaceuticals Holdings Ltd position as of Q4 2014 after selling out during the quarter.
  • Pine River Capital Management sold 73,653 Parnell Pharmaceuticals Holdings Ltd shares in Q4 2014, an estimated $424K.
  • Pine River Capital Management first reported a position in Parnell Pharmaceuticals Holdings Ltd in Q2 2014 and held it in 2 quarters.
  • Pine River Capital Management's Parnell Pharmaceuticals Holdings Ltd position peaked at $508K in Q2 2014.
  • 18 funds tracked by Wall St. Rank held Parnell Pharmaceuticals Holdings Ltd as of Q4 2014.

Based on Pine River Capital Management's 13F filing for Q4 2014, filed 17 Feb 2015.